Current management of gestational diabetes mellitus

References

• Langer O. Management of gestational diabetes: pharmacologic treatment options and glycemic control. Endocrinol. Metab. Clin. North Am.35, 53–78 (2006).
   PubMed Web of Science ®Google Scholar
• Langer O. When diet fails: insulin and oral hypoglycaemic agents as alternatives for management of gestational diabetes mellitus. J. Matern. Fetal Med.11, 218–225 (2002).
   Google Scholar
• Bo S, Menato G, Lezo A et al. Dietary fat and gestational hyperglycaemia. Diabetologia44, 972–978 (2001).
   PubMed Web of Science ®Google Scholar
• Hollander MH, Paarlberg KM, Huisjes AJM. Gestational diabetes: a review of the current literature and guidelines. Obstet. Gynecol. Survey62 (2), 125–136 (2007).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Position statement. Gestational diabetes mellitus. Diabetes Care29(Suppl.) (2006).
   Google Scholar
• Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence fir the U.S. Preventive Service Task Force. Obstet. Gynecol.101, 380–392 (2003).
   PubMed Web of Science ®Google Scholar
• Berger H, Crane J, Farine D. Screening for gestational diabetes mellitus. J. Obstet. Gynaecol. Can.24, 894–912 (2002).
   PubMedGoogle Scholar
• O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes13, 278–285 (1964).
   PubMed Web of Science ®Google Scholar
• Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop Conference on Gestational Diabetes. The Organizing Committee. Diabetes Care21(Suppl. 2), B161–B167 (1998).
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Practice Bulletin – Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001. Gestational diabetes. Obstet. Gynecol.98(3), 525–538 (2001).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Position statement on gestational diabetes mellitus. Diabetes Care27(Suppl. 1), S88–S90 (2004).
   PubMed Web of Science ®Google Scholar
• Major CA, Henry MJ, De Veciana M, Morgan MA. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet. Gynecol.91(4), 600–604 (1998).
   PubMed Web of Science ®Google Scholar
• Nutritional management during pregnancy in pre-existing diabetes. In: American Diabetes Association Medical Management of Pregnancy Cmplicated by Diabetes (3rd Edition). ADA,VA, USA, 70–86 (2000).
   Google Scholar
• Metzger BE, Buchanan TA, Coustan DR et al. Summary and Reccomendations of the Fifth International Workshop–Conference on Gestational Diabetes Mellitus. Diabetes Care30, S251–S260 (2007).
   PubMed Web of Science ®Google Scholar
• Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet. Gynecol.102(4), 857–868 (2003).
   PubMed Web of Science ®Google Scholar
• Rizzo T, Metzger BE, Burns K. Correlations between antepartum maternal metabolism and child intelligence. N. Engl. J. Med.325, 911–916 (1991).
   PubMed Web of Science ®Google Scholar
• Rizzo TA, Dooley SL, Metzger BE, Cho NH, Ogata ES, Silverman BL. Prenatal and perinatal influences on long-term psychomotor development in offspring of diabetic mothers. Am. J. Obstet. Gynecol.173(6), 1753–1758 (1995).
   PubMed Web of Science ®Google Scholar
• Algert S, Shragg P, Hollingsworth DR. Moderate caloric restriction in obese women with gestational diabetes. Obstet. Gynecol.65, 487–491 (Level II-2) (1985).
   PubMed Web of Science ®Google Scholar
• Dyck R, Klomp H, Tan LK, Turnell RW, Boctor MA. A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district. Diabetes Care25(25), 487–493 (2002).
   PubMed Web of Science ®Google Scholar
• Dempsey JC, Butler CL, Sorensen TK et al. A case–control study of maternal recreational physical activity and risk of gestational diabetes mellitus. Diabetes Res. Clin. Pract.66(2), 203–215 (2004).
   PubMed Web of Science ®Google Scholar
• Dempsey JC, Sorensen TK, Williams MA et al. Prospective study of gestational diabetes mellitus risk in relation to maternal recreational physical activity before and during pregnancy. Am. J. Epidemiol.159(7), 663–670 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang C, Solomon CG, Manson JE, Hu FB. A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus. Arch. Intern. Med.166, 543–548 (2006).
   PubMed Web of Science ®Google Scholar
• Jovanovic-Peterson L, Peterson CM. Exercise and the nutritional management of diabetes during pregnancy. Obstet. Gynecol. Clin. North. Am.23, 75–86 (1996).
   PubMed Web of Science ®Google Scholar
• Bung P, Artal R. Gestational diabetes and exercise: a survey. Semin. Perinatol.20, 328–333 (1996).
   PubMed Web of Science ®Google Scholar
• Artal R. Exercise: the alternative therapeutic intervention for gestational diabetes. Clin. Obstet. Gynecol.46(2), 479–487 (2003).
   PubMed Web of Science ®Google Scholar
• Artal R, Bellman O, Dekets T et al. Summary and recommendations of the Second International Workshop–Conference on Gestational Diabetes Mellitus: therapeutic strategies. Diabetes34, 125 (1985).
   Google Scholar
• Jovanovic-Peterson L, Durak EP, Peterson CM. Randomized trial of diet vs diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am. J. Obstet. Gynecol.161, 415–419 (1989).
   PubMed Web of Science ®Google Scholar
• Avery MD, Leon AS, Kopher RA. Effects of a partially home-based exercise program for women with gestational diabetes. Obstet. Gynecol.89, 10–15 (1997).
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee Opinion. Exercise during pregnancy and the postpartum period. 99(1), 171–173 (2002).
   Google Scholar
• Brankston GN, Mitchell BF, Ryan EA, Okun NB. Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus. Am. J. Obstet. Gynecol.190, 188–193 (2004).
   PubMed Web of Science ®Google Scholar
• Ceysens G, Rouiller D, Boulvain M. Exercise for diabetic pregnant women. Cochrane Database Syst. Rev.3, CD004225 (2006).
   Google Scholar
• [no author listed] Impact of physical activity during pregnancy and postpartum on chronic disease risk. Med. Sci. Sports Exerc.38(5), 989–1006 (2006).
   PubMed Web of Science ®Google Scholar
• Artal R, O’Toole M. Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period. Br. J. Sports Med.37(1), 6–12 (2003).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complication. Diabetes Care26 (Suppl. 1), S51–S61 (2003).
   PubMedGoogle Scholar
• Turok DK, Ratcliffe SD, Baxley EG. Management of gestational diabetes mellitus. Am. Fam. Physician68, 1767–1772 (2003).
   PubMed Web of Science ®Google Scholar
• Lindsay MK, Graves W, Klein L. The relationship of one abnormal glucose tolerance test value and pregnancy complications. Obstet. Gynecol.73, 103–106 (1989).
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists No.30. Obstet. Gynecol.98(3), 525–538 (2001).
   Google Scholar
• De Veciana M, Major CA, Morgan MA et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N. Engl. J. Med.333, 1237–1241 (1995).
   PubMed Web of Science ®Google Scholar
• Chen R, Yogev Y, Ben-Haroush A et al. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J. Matern. Fetal Med.14, 256–260 (2003).
   Google Scholar
• McLachlan K, Jenkins A, O’Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust. N. Z. J. Obstet. Gynaecol.47(3), 186–190 (2007).
   PubMed Web of Science ®Google Scholar
• Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res. Clin. Pract.77(2), 174–179 (2007).
   PubMed Web of Science ®Google Scholar
• Genuth SM, Gebhart SSP, Friedman EA et al. Special situation. In: The CADRE Handbook of Diabetes Management. Cefalu WT, Gerich JE, LeRoith D (Eds). Medical Information Press, NY, USA (2004).
   Google Scholar
• Buchanan TA, Kjos SL, Montoro MN et al. Use of fetal ultrasounds to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care17, 275–283 (1994).
   PubMed Web of Science ®Google Scholar
• Bühling KJ, Winkel T, Wolf C et al. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System. J. Perinat. Med.33, 125–131 (2005).
   PubMed Web of Science ®Google Scholar
• Parretti E, Mecacci F, Papini M et al. Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies. Diabetes Care24, 1319–1323 (2001).
   PubMed Web of Science ®Google Scholar
• Yogev Y, Ben-Haroush A, Chen R et al. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am. J. Obstet. Gynecol.191, 1655–1660 (2004).
   PubMed Web of Science ®Google Scholar
• McFarland MB, Langer O, Conway DL et al. Dietary therapy for gestational diabetes: how long is long enough? Obstet. Gynecol.93, 978–982 (1999).
   PubMed Web of Science ®Google Scholar
• Hirsch IB. Insulin Analogues. N. Engl. J. Med.352 (2), 174–183 (2005).
   PubMed Web of Science ®Google Scholar
• Lapolla A, Dalfra MG, Fedele D. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool? Diabetes Metab. Res. Rev.21(3), 241–252 (2005).
   Google Scholar
• Holcberg G, Tsadkin-Tamir M, Sapir O et al. Transfer of insulin lispro across the human placenta. Eur. J. Obstet. Gynecol. Reprod. Biol.115(1), 117–118 (2004).
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Kinsley B, Amiel SA et al. Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in Type1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care.30(4), 771–776 (2007).
   PubMed Web of Science ®Google Scholar
• Owens D, Vora J. Insulin aspart: a review. Expert Opin. Drug Metab. Toxicol.2(5), 793–804 (2006).
   PubMed Web of Science ®Google Scholar
• Garg SK, Ellis SL, Ulrich H. Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes. Expert Opin. Pharmacother.6, 643–651 (2005).
   PubMed Web of Science ®Google Scholar
• Bolli GB, Owens DR. Insulin glargine. Lancet356(9228), 443–445 (2000).
   PubMed Web of Science ®Google Scholar
• Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int. J. Toxicol.21(3), 181–189 (2002).
   PubMed Web of Science ®Google Scholar
• Hussar DA. New drugs 07, part I. Nursing37(2), 51–58 (2007).
   PubMedGoogle Scholar
• Vague P, Selam JL, Skeie S et al. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with Type 1 diabetes on a basal-bolus regimen with premeal insulin aspart. Diabetes Care26(3), 590–596 (2003).
   PubMed Web of Science ®Google Scholar
• Bott S, Tusek C, Jacobsen LV, Kristensen A, Heise T. Insulin detemir reaches steady-state after the first day of treatment and shows a peakless time–action profile with twice-daily applications. In: International Diabetes Federation Abstract Volume of the18th Congress. Paris, France (2003).
   Google Scholar
• Langer O, Anyaegbunam A, Brustman L. Pregestational diabetes: insulin requirements throughout pregnancy. Am. J. Obstet. Gynecol.159, 616–662 (1988).
   PubMed Web of Science ®Google Scholar
• DeWitt DE, Hirsch IB. Outpatient insulin therapy in Type 1 and Type 2 diabetes mellitus. JAMA289, 2254–2264 (2003).
   PubMed Web of Science ®Google Scholar
• Farrar D, Tuffnell Dj, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst. Rev.18(3) (2007).
   Google Scholar
• Mukhopadhyay A, Farrell T, Fraser RB. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am. J. Obstet. Gynecol.3 (2007) (Epub ahead of print).
   Google Scholar
• Langer O. Oral hypoglycaemic agents in pregnancy: their time has come. J. Matern. Fetal Med.12, 376–383 (2002).
   Google Scholar
• De Veciana M. A comparison of oral acarbose and insulin in women with Gestational Diabetes Mellitus. Obstet. Gynecol.99, 5 (2002).
   Google Scholar
• Zarate A, Ochoa R, Hernandez et al. Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy. Ginecol. Obstet. Mex.68, 42–45 (2000).
   PubMedGoogle Scholar
• Langer O, Conway DL, Berkus MD. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med.343, 1134–1138 (2000).
   PubMed Web of Science ®Google Scholar
• Feig DS, Briggs GG, Kmenser JM. Transfer of glyburide and glipzide into breast milk. Diabetes Care28, 1851–1855 (2005).
   PubMed Web of Science ®Google Scholar
• Langer O, Yogev Y, Xenakis EMG. Insulin and glyburide therapy: dosage, severity level of gestational diabetes and pregnancy outcome. Am. J. Obstet. Gynecol.192, 134–139 (2004).
   Web of Science ®Google Scholar
• Yogev Y, Ben-Haroush A, Chen R. Undiagnosed asymptomatic hypoglycaemia: diet, insulin and glyburide for gestational diabetic pregnancy. Obstet. Gynecol.104, 88–93 (2004).
   PubMed Web of Science ®Google Scholar
• Jacobson GF, Ramos GA, Ching JY et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am. J. Obstet. Gynecol.193, 118–124 (2005).
   PubMed Web of Science ®Google Scholar
• Homko CJ, Reece EA. Insulins and oral hypoglycaemic agents in pregnancy. J. Matern. Fetal Med.19(11), 679–686 (2006).
   Google Scholar
• Hawthorne G. Metformin use and diabetic pregnancy- has its time come? Diabetic Med.23, 223–227 (2006).
   PubMed Web of Science ®Google Scholar
• Goetzel I, Wilkins I. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J. Perinatol.22, 403–406 (2002).
   PubMedGoogle Scholar
• Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fert. Steril.86(3), 658–663 (2006).
   PubMed Web of Science ®Google Scholar
• McCarthy EA, Walker SP, McLachlan K et al. Metformin in obstetric and gynaecologic practice: a review. Obstet. Gynecol. Surv.59(2), 118–127 (2004).
   PubMed Web of Science ®Google Scholar
• Gardiner SJ, Kirkpatrick CM, Begg EJ et al. Transfer of metformin into human milk. Clin. Pharmacol. Ther.73, 71–77 (2003).
   PubMed Web of Science ®Google Scholar
• Checa MA, Requena A, Salvador C et al. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary sindrome. Hum. Reprod. Update11(4), 375–390 (2005).
   PubMed Web of Science ®Google Scholar
• Norman RJ, Wang JX, Hague W. Should we continue or stop insulin sensitizing drugs during pregnancy? Curr. Opin. Obstet. Gynecol.16, 245–250 (2004).
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Wang P, Kobayashi S et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil. Steril.77(3), 520–525 (2002).
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycistic ovary syndrome treated with metformin. Hum. Reprod.17(11), 2858–2864 (2002).
   PubMed Web of Science ®Google Scholar
• Jakubowicz DJ, Iuorno MJ, Jakubowicz S et al. effects of metformin on early pregnancy, loss in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab.87, 524–529 (2002).
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N, Pranikoff J et al. Height, weight and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum. Reprod.19(6), 1323–1330 (2004).
   PubMed Web of Science ®Google Scholar
• Vanky E, Salvesen KA, Heimstad R et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum. Reprod.19(8), 1734–1740 (2004).
   PubMed Web of Science ®Google Scholar
• Reece EA, Homko CJ. Metformin in pregnancy: ready or not. Curr. Opin. Endocrinol. Diabetes13, 185–190 (2006).
   Google Scholar
• Hague WM, Davoren PM, Oliver D, Rowan J. Metformin may be useful in gestational diabetes. BMJ326, 762–763 (2003).
   PubMed Web of Science ®Google Scholar
• Hughes RCE, Rowan JA. Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome? Diabet. Med.23, 318–322 (2006).
   Web of Science ®Google Scholar
• Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet. Med.17, 507–511 (2000).
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Bornovali S, Pranikoff J et al. Metformin, pre-eclampsia and pregnancy outcomes in women with polycystic ovary syndrome. Diabet. Med.21, 829–836 (2004).
   PubMed Web of Science ®Google Scholar
• Gabbe SG, Mestman JH, Freeman RK et al. Management and outcome of Class A diabetes mellitus. Am. J. Obstet. Gynecol.127, 465–469 (1977).
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR. Effect of the treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med.352(24), 2477–2486 (2005).
   PubMed Web of Science ®Google Scholar
• Evans E, Patry R. Management of gestational diabetes mellitus and pharmacists’role in patient education. Am. J. Health Syst. Pharm.61, 1460–1465 (2004).
   PubMed Web of Science ®Google Scholar
• Jensen D, Sorensen B, Feilberg-Jorgensen N et al. Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet. Med.17, 281–286 (2000).
   PubMed Web of Science ®Google Scholar
• Casey B, Lucas M, McIntire D et al. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet. Gynecol.90, 869–873 (1997).
   PubMed Web of Science ®Google Scholar
• Boulet SL, Salihu HM, Alexander GR. Mode of delivery and birth outcomes of macrosomic infants. J. Obstet. Gynaecol.24 (6), 622–629 (2004).
   PubMedGoogle Scholar
• Acker DB, Sachs BP, Friedman EA. Risk factors for shoulder dystocia. Obstet. Gynecol.66, 762–768 (1985).
   PubMed Web of Science ®Google Scholar
• Major C, deVeciana M, Weeks J et al. Recurrence of gestational diabetes: who is at risk? Am. J. Obstet. Gynecol.179, 1038–1042 (1998).
   PubMed Web of Science ®Google Scholar
• Nahum GG, Stanislaw H. Ultrasonographic prediction of term birth weigh: how accurate is it? Am. J. Obstet. Gynecol.188, 566–574 (2003).
   PubMed Web of Science ®Google Scholar
• Herbst MA. Treatment of suspected fetal macrosomia: a cost–effectiveness analysis. Am. J. Obstet. Gynecol.193(Suppl. 1), 1035–1039 (2005).
   PubMed Web of Science ®Google Scholar
• Kjos SL, Henry OA, Montoro M et al. Insulin-requiring diabetes in pregnacy: a randomized trial of active induction of labor and expectant management. Am. J. Obstet. Gynecol.169, 611–615 (1993).
   PubMed Web of Science ®Google Scholar
• Lurie S, Insler V, Hagay ZJ. Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients Class A2. Am. J. Perinatol.13, 293–296 (1996).
   PubMed Web of Science ®Google Scholar
• Irion O, Bouvain M. Induction of labor for suspected fetal macrosomia. The Cochrane Library Issue2 (2004).
   Google Scholar
• Rayburn WF, Sokkary N, Clokey DE et al. Consequences of routine delivery at 38 weeks for A-2 gestational diabetes. J. Matern. Fetal Med.18(5), 333–337 (2005).
   Google Scholar
• Peled Y, Perri T, Cen R et al. Gestational diabetes mellitus – implications of different treatment protocols. J. Pediatr. Endocrinol. Metab.17(6), 847–852 (2004).
   PubMed Web of Science ®Google Scholar
• Tuffnell DJ, West J, Walkinshaw SA. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database Syst. Rev.2, CD003395 (2005).
   Google Scholar
• Berger H, Crane J, Farine D. Screening for gestational diabetes mellitus. J. Obstet. Gynaecol. Can.24, 894–912 (2002).
   PubMedGoogle Scholar
• Haeusler MC, Konstantiniuk P, Dorfer M, Weiss PA. Amniotic fluid insulin testing in gestational diabetes: safety and acceptance of amniocentesis. Am. J. Obstet. Gynecol.179(4), 917–920 (1998).
   PubMed Web of Science ®Google Scholar
• Fraser RB, Bruce C. Amniotic fluid insulin levels identify the fetus at risk of neonatal hypoglycaemia. Diabet. Med.16(7), 568–572 (1999).
   PubMed Web of Science ®Google Scholar
• Caplan RH, Pagliara AS, Beguin EA et al. Constant intravenous insulin infusion during labor and delivery in diabetes mellitus. Diabetes Care5, 6–10 (1982).
   PubMed Web of Science ®Google Scholar
• Golde SH, Good-Anderson B, Montoro M. Insulin requirements during labour: a reappraisal. Am. J. Obstet. Gynecol.144, 556–559 (1982).
   PubMed Web of Science ®Google Scholar
• Jovanovic L. Glucose and insulin requirements during labour and delivery: the case for normoglycemia in pregnancies complicated by diabetes. Endocr. Pract.10(Suppl. 2), 40–45 (2004).
   PubMedGoogle Scholar
• Rosenberg VA, Eglinton GS, Rauch ER. Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am. J. Obstet. Gynecol.195, 1095–1099 (2006).
   PubMed Web of Science ®Google Scholar
• Kim C, Herman WH, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care30(5), 1102–1106 (2007).
   PubMed Web of Science ®Google Scholar
• Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of Type 2 diabetes: a systematic review. Diabetes Care25, 1862–1868 (2002).
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol.144, 768–773 (1982).
   PubMed Web of Science ®Google Scholar
• National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes28, 1039–1057 (1979).
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Zimmet PZ; for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med.15, 539–553 (1998).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Gestational diabetes mellitus. Diabetes Care26(Suppl. 1), S103–-S105 (2003).
   PubMed Web of Science ®Google Scholar
• Meltzer S, Leiter L, Daneman D et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ159(Suppl. 8), S1–S29 (1998).
   PubMed Web of Science ®Google Scholar
• Jovanovic L, Ilic S, Pettitt DJ, Hugo K et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care22(9), 1422–1427 (1999).
   PubMed Web of Science ®Google Scholar
• Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin lispro across the human placenta: in vitro perfusion studies. Diabetes Care26(5), 1390–1394 (2003).
   PubMed Web of Science ®Google Scholar
• Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro. N. Engl. J. Med.337(14), 1009–1010 (1997).
   PubMed Web of Science ®Google Scholar
• Buchbinder A, Miodovnik M, McElvy S et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am. J. Obstet. Gynecol.183(5), 1162–1165 (2000).
   PubMed Web of Science ®Google Scholar
• Idama TO, Lindow SW, French M, Masson EA. Preliminary experience with the use of insulin lispro in pregnant diabetic women. J. Obstet. Gynaecol.21(4), 350–351 (2001).
   PubMedGoogle Scholar
• Bhattacharyya A, Brown S, Hughes S, Vice PA. Insulin lispro and regular insulin in pregnancy. QJM94(5), 255–260 (2001).
   PubMed Web of Science ®Google Scholar
• Persson B, Swahn ML, Hjertberg R et al. Insulin lispro therapy in pregnancies complicated by Type 1 diabetes mellitus. Diabetes Res. Clin. Pract.58(2), 115–121 (2002).
   PubMed Web of Science ®Google Scholar
• Garg SK, Frias JP, Anil S, Gottlieb PA, MacKenzie T, Jackson WE. Insulin lispro therapy in pregnancies complicated by Type 1 diabetes: glycemic control and maternal and fetal outcomes. Endocr. Pract.9(3), 187–193 (2003).
   PubMedGoogle Scholar
• Masson EA, Patmore JE, Brash PD et al. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). Diabet. Med.20(1), 46–50 (2003).
   PubMed Web of Science ®Google Scholar
• Cypryk K, Sobczak M, Pertynska-Marczewska M et al. Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy. Med. Sci. Monit.10(2), PI29–PI32 (2004).
   PubMedGoogle Scholar
• Wyatt JW, Frias JL, Hoyme HE et al. IONS study group. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet. Med.22(6), 803–807 (2005).
   PubMed Web of Science ®Google Scholar
• Kitzmiller JL, Main E, Ward B, Theiss T, Peterson DL. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care22(5), 874–876 (1999).
   PubMed Web of Science ®Google Scholar
• Bhattacharyya A, Vice PA. Insulin lispro, pregnancy, and retinopathy. Diabetes Care22(12), 2101–2104 (1999).
   PubMed Web of Science ®Google Scholar
• Loukovaara S, Immonen I, Teramo KA, Kaaja R. Progression of retinopathy during pregnancy in Type 1 diabetic women treated with insulin lispro. Diabetes Care26(4), 1193–1198 (2003).
   PubMed Web of Science ®Google Scholar
• Carr KJ, Idama TO, Masson EA, Ellis K, Lindow SW. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with Type 1 diabetes-the effect on glycaemic excursion. J. Obstet. Gynaecol.24(4), 382–386 (2004).
   PubMedGoogle Scholar
• Mecacci F, Carignani L, Cioni R et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol.111(1), 19–24 (2003).
   PubMed Web of Science ®Google Scholar
• Lindholm A, Jensen LB, Home PD, Raskin P, Boehm BO, Rastam J. Immune responses to insulin aspart and biphasic insulin aspart in people with Type 1 and Type 2 diabetes. Diabetes Care25(5), 876–882 (2002).
   PubMed Web of Science ®Google Scholar
• Pettitt DJ, Ospina P, Kolaczynski JW, Jovanovic L. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care26(1), 183–186 (2003).
   PubMed Web of Science ®Google Scholar
• Devlin JT, Hothersall L, Wilkis JL. Use of insulin glargine during pregnancy in a Type 1 diabetic woman. Diabetes Care25(6), 1095–1096 (2002).
   PubMed Web of Science ®Google Scholar
• Holstein A, Plaschke A, Egberts EH. Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes. Diabet. Med.20(9), 779–780 (2003).
   PubMed Web of Science ®Google Scholar
• Zeszutek SL, Henderson CE, Machupalli S, Marcano H, O’Kane G. A descriptive study: long-acting analogue use in pregnancy. Obstet. Gynecol.101(4), S35 (2003).
   Google Scholar
• Dolci M, Mori M, Baccetti F. Use of glargine insulin before and during pregnancy in a woman with Type 1 diabetes and Addison’s Disease. Diabetes Care28, 2084–2085 (2005).
   PubMedGoogle Scholar
• Di Cianni G, Volpe L, Lencioni C et al. Use of insulin glargine during the first weeks of pregnancy in five Type 1 diabetic women. Diabetes Care28(4), 982–983 (2005).
   PubMed Web of Science ®Google Scholar
• Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven Type 1 diabetic women. Diabetes Care.28(10), 2594–2595 (2005).
   PubMed Web of Science ®Google Scholar
• Caronna S, Cioni F, Dall’Aglio E, Arsenio L. Pregnancy and the long-acting insulin analogue: a case study. Acta Biomed.77(1), 24–26 (2006).
   PubMedGoogle Scholar
• Graves DE, White JC, Kirk JK. The use of insulin glargine with gestational diabetes mellitus. Diabetes Care.29(2), 471–472 (2006).
   PubMed Web of Science ®Google Scholar
• Cechurova D, Lacigova S, Jankovec Z et al. The insulin analog glargine during an unplanned pregnancy. Wien Klin. Wochenschr.118(19–20), 619–620 (2006).
   PubMed Web of Science ®Google Scholar
• Torlone E, Gennarini A, Ricci NB, Bolli GB. Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women. Eur. J. Obstet. Gynecol. Reprod. Biol.132(2), 238–923 (2007).
   PubMed Web of Science ®Google Scholar
• Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: a case–control pilot study. Br. J. Obstet. Gynecol.114(4), 453–457 (2007).
   Google Scholar